Risks related to the uncontrolled development of pharmacognosia in the US and France;Risques lies a l'essor incontrole de la pharmacognosie aux Etats-Unis et en France

Annales Pharmaceutiques Francaises

Volumn 58, Issue 1, 2000, Pages 35-42

  Delaveau, P ^a   Boudéne, Cl ^b  

^a Academie nationale de pharmacie   (France)

^b Centre de Recherches Toxicologiques   (France)

Author keywords

Adulterations; French regulation; Medical herbs; Poisonings; US regulation

Indexed keywords

DRUG ACTIVITY; DRUG CONTROL; DRUG DEVELOPMENT; DRUG MARKETING; DRUG SAFETY; FRANCE; HEALTH CARE ORGANIZATION; HERBAL MEDICINE; MEDICINAL PLANT; NONHUMAN; PHARMACOGNOSY; REVIEW; UNITED STATES; HUMAN; LEGAL ASPECT; RISK FACTOR; SAFETY;

FRANCE; HUMANS; PHARMACOGNOSY; PLANTS, MEDICINAL; RISK FACTORS; SAFETY; UNITED STATES;

EID: 0033628423     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Kouzi SA. Herbal Remedies · The Design of a New Course in Pharmacy. Am J Pharm Educ 1996; 60: 358-64.
2. Ernst E. Harmless Herbs, a Review of the Recent Litterature. Am J Med 1998; 104: 170-8.
3. Ka Kit Hui. Is there a Role for Traditional Chinese medicine? JAMA 1997; 277: 9-714.
4. Anon. Flore de Chine. La Recherche nov 1998; 314: 25.
5. Chuan Li, Masato Homma Kitaro Oka. Chromatographic identification of phenolic compounds in human urine following oral administration of the herbal medicines Daisoko-to and Shosatko-to. J Chromatography 1997; 693: 191-8.
6. Zhu Da-Yuan, Bai Dong-Lu Tang Xio-Can Recent Studies on Traditional Chinese medicinal Plants. Drug Development Res 1996; 39: 147-57.
7. Borchers AT, Hackman RM, Keen CL, Stern J Gershwin E. Complementarity medicine: a review of immunomodulatory effects of Chinese herbal medicine. Am J Clin Nutr 1997; 66: 1303-12.
8. Skolnick AA. Old Chinese Herbal Used for Fever Yields Possible New Alzheimer Disease Therapy. JAMA 1997; 277: 10, 776-8.
9. Bensoussan A, Tailey NJ, Hing M, Menziez R, Guo A, Ngu M. Treatment of Irritable Bowel Syndrome With Chinese Herbal Medicine. A Randomized Controlled Trial. JAMA 1998; 280: 18, 1585-9.
10. Senior K. Chinese herbs calm irritable bowels. Lancet 1998; 352: 1605.
11. Harper JI, Yang SL, Evans AT, Evans FJ, Phillipson JD Chinese herbs for eczema. Lancet 1990; 335: 795.
12. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Draptwa M, Jadoul M et al. Rapid progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-91.
13. Jackson L, Kofman S, Weiss A, Brodowsky H. Aristolochic acid: phase I clinical study. Cancer Chemoth Reports 1964, 42: 35-7.
14. Pourrat J, Montastruc JL, Lacombe JL, Cisterne JM, Rascol O, Dumazer Ph. Néphropathie associée à des herbes chinoises 2 cas. Presse Méd 1994; 23: 36, 1669.
15. Vanhaelen M, Vanhaelen-Fastre R, But P Vanherwegeghem. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343: 174.
16. Hashimoto K, Higuchi M, Makino B, Sakakibara I, Kubo M, Komatsu Y et al. Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol 1999; 64: 185-9.
17. Mens U, Stotzem CD. Renal Toxicity of Aristolochic acid in Rats as an Example of Nephrotoxicity Testig in Routine Toxicology. Arch Toxicol 1993; 637: 307-11.
18. Bieler Ch A, Stiborova M, Wiessler M, Cosyns JP, van Ypersele de Strihou Ch, Schmeiser HH. 32p-post-labelling analysis of DMA adducts formed by aristolochic acid in tissue from patients with Chinese herbs nephropathy. Carcinogenesis 1997; 18: 5, 1063-7.
19. Schmeiser HH, Bieler Ch A, Wiesler M, van Ypersele de Strihou Ch, Cosyns JP. Detection of DNA Adducts Formed by Aristolochic Acid in Renal Tissue from Patients with Chinese herbs Nephropathy. Cancer Res 1996; 56: 2025-8.
20. Gotzl E, Schimmer O. Mutagenicity of aristolochic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 1993; 8, 17-22.
21. Espinoza EO, Mann MJ, Bleasdell B. Arsenic and mercury in traditional Chinese herbal balls. New England J Med 1995; 333: 12, 803-4.
22. Ko RJ. Adulterants in Asian Patent Medicines. New England J Med 1998; 339: 847.
23. Yu H, Zhong S, Chan K, Berry M. Pharmacognostical investigations on traditional Chinese medicinal herbs: identification of four herbs from the UK market. J Pharm Pharmacol 1995; 47, 1129.
24. Beigel Y, Ostfeld I, Schoenfeld N. A Leading Question. New England J Med 1998; 339: 827-30.
25. Halt M. Moulds and mycotoxins in herb tea and medicinal plants. Europ J Epidem 1998; 14: 269.
26. Keane FM, Munn SE, du Vivier AW, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. Brit Med J 1998; 318: 563-4.
27. Gertner E, Marshall PS, Folandrinos D, Potek AS, Smith TM. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995; 33: 5, 467-70.
28. Dipaola RS, Hayan Zhang, Lambert GH, Meekers R, Licitra E, Rafi MM et al. Clinical and biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. New England J Med 1998; 339: 785-91.
29. Nelson L, Shih R, Huffman R. Aplastic anemia induced by an adulterated herbal medication. Clin Toxicol 1995; 33: 5, 467-70.
30. Raman A, Jamal J. Herbal hay fever remedy found to contain conventional drugs. Pharmaceutical J 1997; 258: 105-6.
31. Higenbottam TW. Bronchiolitis obliterans following the ingestion of an Asian shrub leaf. Thorax 1997; 52: S68-S72.
32. Heki U, Fujimura M, Ogawa H, Matsuda T, Kitagawa M. Pneumonitis caused by Saikokeisikankyou-tou, an Herbal Drug. Intern Med 1997; 36: 3, 214-7.
33. Lin TJ, Lu CC, Chenk W, Deng JF. Outbreak of obstructive ventilatory impairment associated with consumption of Sauropus androgynus vegetable. Clin Toxicol 1996; 34, 1-8.
34. Boyle FM. Adverse interaction of herbal medicine with breast cancer treatment. Med J Austral 1997; 167: 5, 286.
35. Ishikawa K, Matsui K, Madarame T, Sato S, Oikawa K, Uchida T, Hepatitis E probably contracted via a Chinese herbal medicine, demonstrated by nucleotide sequencing. J Gastroenterol 1995; 30: 534-8.
36. Yoshida EM, Mclean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, Lake JR. Chinese herbal medicine, Fulminant Hepatitis, and Liver Transplantation. Am J Gastroenterol 1996; 91: 12, 2647-8.
37. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product. Ma Huang. Am J Gastroenterol 1996; 91: 1436-8.
38. Kamiyana T, Nouchi T, Kojima S, Murata N, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703-4.
39. Hamid S, Rojter S, Vierling J. Protected cholesiatic hepatitis after the use of prostata. Ann Intern Med 1997; 127: 169-70.
40. De Smet PAGM, van den Eertwegh AJM, Lesterhuis W, Styricker BHCH. Hepatotoxicity associated with herbal tablets. Brit Med J 1997; 48: 249-52.
41. Sheikh NM, Philen RM, Love LA. Chapparal-Associated hepatotoxicity. Arch Intern Med 1997; 157: 913-9.
42. Batchelor WE, Heathcote J, Wanless JR. Chapparal-induced hepatic injury. Am J Gastroenterol 1995; 90: 831-9.
43. Gordon DW, Rosenthal G, Hart J, Sirota R, Baker AL. Chapparal ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273: 6, 489-490.
44. Tanaka A, Shinkai S, Maeda K, Murata M, Seta K, Okuda J et al. Chinese herbs nephropathy in the kansai area: A warning report. Japan J Nephrol 1997; 39: 438-40.
45. Hilepo JN, Belluci AG, Mossey RT. Acute renal failure caused by cat's claw herbal remedy in a patient with systemic lupus erythematosus. Nephron 1997; 77: 361.
46. Chan Tyk, Chan AYW, Critchley JAJH. Hospital admissions due to adverse reactions to Chinese herbal medicines. J Trop Med Hyg 1992; 95, 296-8.
47. Madsen H, Andersen LLT, Kristoffersen K, Thomlsen BW, Schacke E. Herbal medicine and hormonal side-effects. Ugeskrift Laeger 1997; 159: 2239.
48. Slifman NR, Obermeyer WR, Brend KA, Musser SM, Correll WA et al. Contamination of Botanical Dietary Sup- plements by Digitalis lanata. New England J Med 1998; 339: 806-11.
49. Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a Ma-huang-containing drink. J Clin Psychopharmacol 1997; 17: 437-9.
50. De Smet PAGS. Should herbal medicine-like products be licensed as medicines. Brit Med J 1995; 310: 1023-4.
51. Josefson D. Herbal stimulant causes US deaths. Brit Med J 1996; 312: 1441.
52. Mitka M. FDA Never Promised an Herb garden But Sellers and Buyers Eager to See One Grow. JAMA 1998; 280: 1554-6.
53. Angell M, Kassirer JP. Alternative Medicine The Risk of Untested and Unregulated Remedies. New Engl J Med 1998; 339: 839-41.
54. Dickinson A. Alternative medicines. The case of herbal remedies. New England J Med 1999; 340: 564
55. Cooper RA, Laud P, Dietrich CL. Current and Projected Workforce of Notphysician Clinicians. JAMA 1998; 280: 9, 788-94.
56. Cooper RA, Henderson T, Dietrich CL. Roles of Notphysician Clinicians as Autonomous Providers of Patient Care. JAMA 1998; 280: 9, 795-802.
57. Ernst E, Rand JI, Stevinson C. Complementary Therapies for Depression Arch Gen Psych 1998; 55: 1026-1032.
58. Grumbach K, Coffman J. Physicians and Notphysician Clinicians. Complements or Competitors? JAMA 1998; 280: 9, 825-6.
59. Delaveau P. Regulation on medicinal plants and herbal remedies in Western Europa. First World Congress on Medicinal and Aromatic Plants for Human Welfare. Maastricht 21 juillet 1992 Acta Horticulturae 1993; 332: 31-6.
60. Benzi G, Ceci A. Herbal medicines in European Regulation. Phytopharmacol Res 1997; 35: 5, 355-62.
61. Horn M. La législation belge en matière de plantes: l'approche pragmatique. Méd Nutrition 1999; 35: 1, 22-35.
62. Delaveau P, Dillemann G. Classer les plantes médicinales. Bull Ordre Pharm 1985 ; 282.
63. Deleau N. Médicaments et produits à base de plantes. Aspea réglementaire et surveillance des effets indésirables. Diplôme État Doct Pharrn Paris V ; 1998.